Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MICROGLIAL PHAGOCYTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | MICROGLIAL PHAGOCYTOSIS |
| Key Genes/Proteins | ALZHEIMER DISEASE |
Knowledge base pages for this entity
graph TD
MICROGLIAL_PHAGOCYTOSIS["MICROGLIAL PHAGOCYTOSIS"]
MICROGLIAL_PHAGOCYTOSIS -->|"causes"| Alzheimer_Disease["Alzheimer Disease"]
MICROGLIAL_PHAGOCYTOSIS -->|"involved_in"| Amyloid_Beta["Amyloid-Beta"]
MICROGLIAL_PHAGOCYTOSIS -->|"targets"| Synapses["Synapses"]
MICROGLIAL_PHAGOCYTOSIS -->|"causes"| Synaptic_Loss["Synaptic Loss"]
MICROGLIAL_PHAGOCYTOSIS -->|"contributes to"| Depression["Depression"]
MICROGLIAL_PHAGOCYTOSIS -->|"involved_in"| Alzheimer_s_Disease["Alzheimer's Disease"]
MICROGLIAL_PHAGOCYTOSIS -->|"downregulates"| Synaptic_Density["Synaptic Density"]
Lipid_Droplets["Lipid Droplets"] -->|"inhibits"| MICROGLIAL_PHAGOCYTOSIS
Complement_C1q_C3_CR3_Signalin["Complement C1q/C3-CR3 Signaling Pathway"] -->|"mediates"| MICROGLIAL_PHAGOCYTOSIS
SPP1["SPP1"] -->|"activates"| MICROGLIAL_PHAGOCYTOSIS
C1Q["C1Q"] -->|"mediates"| MICROGLIAL_PHAGOCYTOSIS
C3["C3"] -->|"mediates"| MICROGLIAL_PHAGOCYTOSIS
Complement_C1q_C3_CR3["Complement C1q/C3-CR3"] -->|"mediates"| MICROGLIAL_PHAGOCYTOSIS
C3_Cr3_Signaling_Pathway["C3-Cr3 Signaling Pathway"] -->|"mediates"| MICROGLIAL_PHAGOCYTOSIS
TREM2["TREM2"] -->|"regulates"| MICROGLIAL_PHAGOCYTOSIS| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer Disease | causes | disease | 0.95 |
| Beta-Amyloid Deposition | associated_with | phenotype | 0.93 |
| Synapses | targets | cell_type | 0.90 |
| Synaptic Loss | causes | phenotype | 0.90 |
| Depression | associated_with | disease | 0.90 |
| Alzheimer's Disease | associated_with | disease | 0.85 |
| ALZHEIMER'S DISEASE | involved_in | disease | 0.85 |
| Synaptic Density | downregulates | phenotype | 0.80 |
| Neuroinflammation | inhibits | process | 0.80 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Complement C1q/C3-CR3 Signaling Pathway | mediates | pathway | 0.95 |
| C1Q/C3-CR3 signaling pathway | mediates | pathway | 0.95 |
| reducing lipid droplet load | associated_with | process | 0.95 |
| SPP1 | drives | gene | 0.95 |
| SPP1 | promotes | gene | 0.95 |
| Complement C1q/C3-CR3 | mediates | pathway | 0.95 |
| C3-Cr3 Signaling Pathway | mediates | pathway | 0.95 |
| Lipid Droplets | inhibits | compound | 0.95 |
| C3 | mediates | protein | 0.95 |
| C1Q | mediates | protein | 0.95 |
| SPP1 | activates | gene | 0.95 |
| CX3CL1-CX3CR1 Axis | activates | pathway | 0.93 |
| Lipid Droplet Load | inhibits | phenotype | 0.92 |
| TREM2 | regulates | protein | 0.92 |
| 41240472 | enhanced | paper | 0.90 |
| TREM2 | activates | protein | 0.90 |
| C1q/C3-CR3 signaling pathway | regulates | pathway | 0.90 |
| complement cascade | mediates | pathway | 0.90 |
| Lipid Droplet Formation | inhibits | process | 0.90 |
| TREM2 | modulates | gene | 0.90 |
| TREM2 | enhances | gene | 0.90 |
| SPP1 | upregulates | protein | 0.88 |
| APOE | modulates | gene | 0.85 |
| TREM2 | modulates | gene | 0.85 |
| MSR1 | mediates | gene | 0.85 |
| C1Q Neutralizing Antibody | inhibits | drug | 0.85 |
| Lipid Droplet Accumulation | inhibits | process | 0.85 |
| APOE | inhibits | gene | 0.85 |
| lipid droplet accumulation | inhibits | phenotype | 0.85 |
| C1Q neutralizing antibody | suppresses | drug | 0.85 |
| Amyloid-Beta Oligomers | promotes | compound | 0.85 |
| TREM2/DAP12 signaling | regulates | pathway | 0.85 |
| NLRP3 Inflammasome | inhibits | pathway | 0.85 |
| PSEN1 | implicated_in | gene | 0.80 |
| CD11C | involved_in | receptor | 0.80 |
| CR3 | mediates | receptor | 0.80 |
| C1Q | enhances | gene | 0.80 |
| ALZHEIMER DISEASE | disrupts | gene | 0.80 |
| Lysosomal enzyme activity enhancement | upregulates | process | 0.80 |
| TREM2 | promotes | gene | 0.80 |
| ULK1 | regulates | gene | 0.75 |
| Depression | associated_with | disease | 0.70 |
| TREM2 agonism | activates | process | 0.70 |
| APOE4 | suppresses | gene | 0.70 |
| TREM2 ITAM signaling | activates | pathway | 0.70 |
| C3 | activates | protein | 0.70 |
| stroke | associated_with | disease | 0.70 |
| lysosomal exhaustion | inhibits | process | 0.70 |
| autophagy | regulates | process | 0.70 |
| gamma oscillations at 40Hz | activates | mechanism | 0.70 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.629
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.640
neuroscience | 2026-04-03 | 70 hypotheses Top: 0.964
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| E2F coordination of G2/M transcriptional program | exploratory | 0.750 | 0.00 | endocycling mammalian cells | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| TREM2 in neurodegeneration and diseases. [PMID:41792456] | ["Abdulkhaliq A", "Alasiri G", "Kim B", | Molecular psychiatry | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] | Alhusaini M, Mussa BM, Ilce BY, Alhaj H, | Frontiers in aging neuroscienc | 2026 | 0 |
| Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] | ["Srivastav Jyotsna", "Sharma Sachin"] | Frontiers in medicine | 2025 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.65 · 2026-04-27
closed · Rounds: 4 · Score: 0.71 · 2026-04-27
closed · Rounds: 4 · Score: 0.87 · 2026-04-27
closed · Rounds: 4 · Score: 0.48 · 2026-04-27
closed · Rounds: 4 · Score: 0.54 · 2026-04-27
closed · Rounds: 4 · Score: 0.19 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
Hypotheses and analyses mentioning MICROGLIAL PHAGOCYTOSIS in their description or question text
Score: 0.582 · molecular biology · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on alectinib's potential direct interaction with t
Score: 0.540 · neurodegeneration · 2026-04-21
## Mechanistic Overview P2Y6R activation by UDP from damaged neurons drives microglial phagocytosis and exosomal re-secr
Score: 0.530 · neurodegeneration · 2026-04-25
Cystatin-C-activated TREM2 microglia reduce tau pathology through enhanced phagocytosis of extracellular tau seeds. Crit
Score: 0.491 · neuroscience · 2026-04-21
## Mechanistic Overview GluN2B-Regulated Microglial Phagocytosis of Tau Aggregates via CX3CR1 Signaling starts from the